Using Metabolomics to Study Responders and Non-Responders
Welcome to Panome Bio’s ChatGJP series with CSO Gary J. Patti, Ph.D. In this session, we ask Dr. Patti, “How is metabolomics being used to identify responder and non-responder populations in clinical trials?”
Have a Question?
Your privacy is important to us.
We’ll never share your information.